Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

its primary endpoint at the end of the trial. Based on the DSMB decision, Eli Lilly and Company (Lilly) provided a US $10 million milestone payment to BioMS as part of the terms of the licensing and collaboration agreement. BioMS anticipates MAESTRO-01 will be completed in 2009 with results from the trial expected in the second half of this year. - MAESTRO-02: Eligible patients who have successfully completed MAESTRO-01 may choose to receive dirucotide on an un-blinded basis in this open-label follow-on study. To date, approximately 95% of the eligible patients who have successfully completed the MAESTRO-01 trial have enrolled in this follow-on study. - MAESTRO-03: Enrollment was initiated in June, 2007 and completed on August 1, 2008 for this pivotal U.S. phase III trial of approximately 510 SPMS patients at 67 sites across the U.S. To date, the DSMB has conducted three reviews of the data from this trial and recommended it continue. The next DSMB review is expected to take place in the second quarter of fiscal 2009. - MINDSET-01: MINDSET-01 was a randomized, double-blind study that recruited 218 relapsing-remitting MS patients at 24 trial sites in six countries across Europe. BioMS recently announced that the top line results of this exploratory study did not meet its primary endpoint of effecting annualized relapse rate or associated secondary magnetic resonance imaging (MRI) endpoints. Dirucotide did meet certain secondary endpoints related to the progression of the disease, including mean change from baseline in the EDSS and the MS Functional Composite (MSFC) score. Changes in EDSS and MSFC are primary and secondary outcomes in the ongoing phase III SP
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 Telomere ... of their Nutraceutical "TELO-20 for Dogs" with ... Telomere-lengthening supplement in the world for dogs. Telomeres ... every chromosome in the body. A wealth of ... experts in Telomere Science and Aging, including Nobel ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that the ... and Mexico currently faces ... approved agents, the anticipated label extension of Boehringer ... of emerging biologics will substantially increase the competitiveness ... IL-5 inhibitors will introduce a new dynamic to the ...
(Date:8/21/2014)... YORK , Aug. 21, 2014 ... congratulates Immune Pharmaceuticals Inc., a biotechnology company, on ... Market.  Immune previously traded on OTCQX®, the best ... by OTC Markets Group. Logo - ... Pharmaceuticals on the successful execution of its growth ...
(Date:8/21/2014)... MOUNTAIN VIEW, Calif. , Aug. 21, 2014 ... their properties and behaviors based on external stimuli ... is poised to have a disruptive effect in ... will revolutionize the business landscape by printing objects ... the aerospace and automotive sectors. Logo ...
Breaking Biology Technology:Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4
... , WALTHAM, Mass., Dec. 14 Decision ... pharmaceutical and healthcare issues, finds that, owing to the launches of ... than sevenfold from $790 million in 2008 to $6.1 billion in ... Kingdom and Japan. , The new Pharmacor report entitled Atrial ...
... , , ROCKVILLE, Md., Dec. 11 ... receipt of $1.7 million in royalty revenue from sales of ... of $3.3 million. In addition, the Company anticipates a ... The difference in estimated and actual revenues for the ...
... explanation for differences in the severity of mental illness in males. ... the handicap. The genetic defect is situated on the X-chromosome; and ... the GDI1 gene that is responsible. The results are being published ... the result of work by the group of Guy Froyen connected ...
Cached Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2Amount of gene surplus determines severity of mental retardation in males 2
(Date:8/22/2014)... Calif. Thomson Reuters , a leading source ... researchers at the University of California, Riverside in its ... minds of our times." , To generate the list, ... to identify researchers whose published work has had enormous ... among some 3,200 individuals who published the greatest number ...
(Date:8/22/2014)... Jolla, CA Research presented at the 29th ... being developed by Hera Therapeutics Inc. combats three ... cause 70 percent of all cervical cancer. , ... HTI-1968 blocked the replication of HPV-16, HPV-18 and ... and Thomas Broker, Ph.D., who presented the findings ...
(Date:8/22/2014)... news release is available in French . ... drain of essential nutrients from African soils looming as a ... report released today finds that over the last five years, ... practices that have rejuvenated 1.6 million hectares and helped them ... the Alliance for a Green Revolution in Africa (AGRA) focuses ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 3Effort to confront Africa's soil health crisis helps millions of farmers triple yields 4
... U.S. Department of Energy,s National Renewable Energy Laboratory (NREL) are ... 1982, NREL has won 52 R&D 100 Awards known ... Innovation" for its groundbreaking work. When it came ... computing (HPC) data center, the NREL team knew it would ...
... family Braconidae are known for their deadly reproductive ... eggs developing in other insects and their larvae, eventually killing ... causing its sterility. Three new species of the parasitoid wasp ... Journal of Hymenoptera Research , reflect this fatal behavior. ...
... A compact, self-contained sensor recorded and transmitted brain activity data ... tests, according to a study funded by the National Institutes ... of brain activity in moving subjects, this implantable device represents ... that move with the power of thought. The report is ...
Cached Biology News:New ultra-efficient HPC data center debuts 2New ultra-efficient HPC data center debuts 3New ultra-efficient HPC data center debuts 4New ultra-efficient HPC data center debuts 5New ultra-efficient HPC data center debuts 6New ultra-efficient HPC data center debuts 7Kill Bill character inspires the name of a new parasitoid wasp species 2Wireless, implanted sensor broadens range of brain research 2Wireless, implanted sensor broadens range of brain research 3
... Abpromise for all tested applications). ... from within residues 2000 to the C-terminus ... acid sequence is proprietary) ... Entrez GeneID: 57697 ...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Biology Products: